Correlation between therapy and lipid profile of leprosy patients: is there a higher risk for developing cardiovascular diseases after treatment?

Table 1 Lipid profile of patients with leprosy according to the WHO operational classification

Variable	Paucibacillary (n = 16)	Multibacillary (n = 68)	P
Total cholesterol (mg/dL)
Mean ± SD	193.8 ± 29.4	203.5 ± 41.7	0.3809^a
Median	192	200
Range; CV (%)	143–250; 15.2%	104–291; 20.51%
LDL-c (mg/dL)
Mean ± SD	116.9 ± 22.7	121 ± 31.3	0.6222^a
Median	110.5	116.5
Range; CV (%)	84–163; 19.42%	48–210; 25.86%
HDL-c (mg/dL), male
Mean ± SD	51.7 ± 3.9	52.8 ± 8.6	0.5631^b
Median	52	52
Range; CV (%)	44–57; 7.47%	29–83; 16.24%
HDL-c (mg/dL), female
Mean ± SD	50.2 ± 8.1	53.5 ± 6.3	0.2832^a
Median	48	55
Range; CV (%)	40–62; 16.07%	38–64; 11.83%
Triglycerides (mg/dL)
Mean ± SD	123.4 ± 45.2	147.4 ± 88.9	0.5885^b
Median	127.5	118.5
Range; CV (%)	70–219; 36.65%	69–398; 60.34%

ISSN: 2049-9957